Repeated Injection of I PRF and Autogenous Bone Graft for Alveolar Ridge Augmentation
I-PRF
1 other identifier
interventional
28
1 country
1
Brief Summary
The current st udy's objective was to validate the repeated effect of i PRF with autogenous bone on the of gingival thickness , width a n d volumetric bone changes durig maxillary alveolar augmentation using cone beam computer tomography (CBCT). Patients and methods:
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2024
CompletedFirst Submitted
Initial submission to the registry
November 22, 2024
CompletedFirst Posted
Study publicly available on registry
December 2, 2024
CompletedDecember 2, 2024
November 1, 2024
5 months
November 22, 2024
November 28, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
width of the alveolar ridge
CBCT will be used to assess the width of the alveolar ridge
baseline, 6 months & 9 months
Secondary Outcomes (1)
volumetric analysis of bone
at baseline, 6 and 9 months
Study Arms (2)
control
ACTIVE COMPARATORbone grafting
study
ACTIVE COMPARATORbone grafting \& i PRF
Interventions
autogenous bone augmentation with repeated i-PRF injections
Eligibility Criteria
You may qualify if:
- patients who have a horizontal or vertical alveolar ridge deficiency
You may not qualify if:
- patients showing any signs of active periodontal disease
- patients on long term corticosteroid therapy,
- patients taking bone metabolism drugs
- patients suffering from any systemic illness that may impact bone repair
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Faculty of Dentistry , Al Azhar Univeristy For Girls
Cairo, Heliopolis - Cairo, 123456, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Zainab H Abdel Rahman, Phd
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 22, 2024
First Posted
December 2, 2024
Study Start
April 1, 2024
Primary Completion
September 1, 2024
Study Completion
November 1, 2024
Last Updated
December 2, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share